Andrew Hirsch
Chief Executive Officer bei C4 THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Andrew J.
Hirsch is currently the President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
He is also an Independent Director at Editas Medicine, Inc. since 2017.
Previously, he held positions such as President, CEO, CAO & Director at DNIB Unwind, Inc. from 2012 to 2016, VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011, CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2016 to 2020, and Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch completed his undergraduate degree at the University of Pennsylvania in 1992 and obtained an MBA from the Tuck School of Business at Dartmouth in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
C4 THERAPEUTICS, INC.
0,31% | 15.02.2024 | 210 741 ( 0,31% ) | 2 Mio $ | 31.03.2024 |
EDITAS MEDICINE, INC.
0,00% | 01.06.2023 | 2 000 ( 0,00% ) | 14 840 $ | 31.03.2024 |
Aktive Positionen von Andrew Hirsch
| Unternehmen | Position | Beginn |
|---|---|---|
| EDITAS MEDICINE, INC. | Director/Board Member | 30.05.2017 |
| C4 THERAPEUTICS, INC. | Chief Executive Officer | 02.10.2020 |
Ehemalige bekannte Positionen von Andrew Hirsch
| Unternehmen | Position | Ende |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director of Finance/CFO | 11.09.2020 |
| DNIB UNWIND INC | Chief Executive Officer | 24.07.2016 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Director of Finance/CFO | 31.03.2012 |
| BIOGEN INC. | Corporate Officer/Principal | 01.06.2011 |
Ausbildung von Andrew Hirsch
| University of Pennsylvania | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
